ÂÜÀòÂÒÂ×

Sara Sánchez Gómez is a highly driven, strategic, and patient-focused Genitourinary Country Brand Lead in Oncology at Pfizer, with a strong background in various therapeutic areas including Rare Diseases and Inflammation & Immunology. They have contributed significantly to the launch of Vyndaqel(R) for Transthyretin Amyloid Cardiomyopathy (ATTR-CM) and maintain collaborative relationships with key opinion leaders and scientific societies. They hold a Pharmacy degree from Universidad de Alcalá and an MBA in Pharmaceutical and Biotechnology Leadership from EPHOS Business School. Previously, Sara served in roles such as Pharmacist and Research Student, demonstrating a solid foundation in both clinical and research environments.